Abbott's TEAM-HF Trial Aims Early Intervention in High-Risk Heart Failure

Abbott introduced a unique clinical trial aimed at enhancing results in patients with worsening heart failure who may benefit from advanced treatment choices. The TEAM-HF study aims to include a maximum of 850 participants from 75 locations...

Bayer and Dewpoint Therapeutics Ink Pact for Heart Disease Program

Bayer has made an exclusive deal with Dewpoint Therapeutics, Inc. for a heart disease program targeting dilated cardiomyopathy (DCM) patients with specific mutations. This marks the initial opportunity for collaboration between Bayer and Dewpoint...

Matica Biotech and KaliVir Ink LOI for Oncolytic Viral Immunotherapy Ties

Matica Biotechnology Inc. (Matica Bio), a company specializing in viral vector development and manufacturing, has revealed the signing of a Letter of Intent (LOI) with KaliVir Immunotherapeutics, a clinical-stage biotechnology company from the U.S...

Merck's Keytruda Bags European Nod for indications in Gynaecologic Cancers

Merck, a leading pharmaceutical firm, stated that Keytruda (pembrolizumab), their anti-PD-1 therapy, has received approval from the European Commission (EC) for two additional uses in gynaecologic cancers. Keytruda has received initial approval...

Thermo Fisher and Telangana Govt to Set Up Bioprocess Design Centre

Thermo Fisher Scientific signed a Memorandum of Understanding (MoU) with the Telangana Government to set up a bioprocess design centre (BDC) in Genome Valley, Hyderabad. With a total area of 10,000 sq. ft., the bioprocess design center is...

The Pharma Manufacturing & Automation Excellence Awards 2024 - A Celebration of Innovation, Excellence, and Leadership

The Pharma Manufacturing & Automation Excellence Awards 2024, hosted by Eminence Business Media, witnessed an incredible night of celebration, innovation, and recognition, marking the maiden edition of what promises to become a hallmark event.

The 6th Annual Pharma Manufacturing and Automation Convention 2024 took place in Hyderabad

The 6th Annual Pharma Manufacturing and Automation Convention 2024 took place on October 17th and 18th at the Hotel Westin Mindspace in Hyderabad. The event brought together industry leaders to discuss the future of intelligent manufacturing.

Eli Lilly's Donanemab Secures MHRA Approval for Alzheimer's Treatment

Eli Lilly and Company, a pharmaceutical company that uses science to improve lives globally, has revealed that the Medicines and Healthcare products Regulatory Agency (MHRA) has approved the marketing of donanemab, an injection for intravenous...

BSV Boosts R&D with In-House Biologics, Expands Women's Health Portfolio

BSV, Bharat Serums and Vaccines Ltd, has created innovative biologic products internally, showcasing their impressive research and development skills. They have a diverse collection of branded products in women's health, fertility, critical care...

Oblique Therapeutics and Eli Lilly Partner for Antibody Development

Oblique Therapeutics, a top biotech company focused on creating new drugs, has partnered with Eli Lilly and Company (Lilly) to use the AbiProt technology in developing antibodies for a valuable target. This collaboration is designed to speed up...

© 2024 India Pharma Outlook. All Rights Reserved.